Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artelac Splash Edo is a preservative-free ophthalmic solution formulated for the rapid and long-lasting relief of dry, irritated, or tired eyes. Its main active ingredient is hyaluronic acid (as sodium hyaluronate) at a concentration of 0.2%. Hyaluronic acid acts as a natural moisturizer by binding water in the tear film and improving its stability, thereby alleviating symptoms associated with reduced tear production or environmental stressors such as screen use, air conditioning, or contact lens wear. The product comes in single-dose units for convenient and hygienic application on the go[1][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Artelac Splash Edo.